Companies
Ankon Technologies
develops magnetically controlled capsule endoscopy, in which an external magnet steers the swallowed capsule's position and orientation for a more complete GI examination than passive transit alone.
- Country
- China
Commercial
Magnetically controlled capsule endoscopy
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $113.5 million total raised | healthtechalpha.com |
| Capacity | 1 million units per year | chinadaily.com.cn |
| Certification | EU CE certification | hosencare.com · ankoninc.com.cn |
| Regulatory approval | China NMPA Class III medical device registration certificate, US FDA De Novo classification | hosencare.com · ankoninc.com.cn |
| Headcount | 200 employees as of 2025 | qiye.qizhidao.com |
| Revenue | 322 million RMB in 2018 | qiye.qizhidao.com |
Independent sources: ankoninc.com.cn · chinadaily.com.cn · healthtechalpha.com · hosencare.com · qiye.qizhidao.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Ingestible biosensors / smart pills | diagnostics-medtech | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.